Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Does Heparin Coating Improve Patency or Reduce Infection of Tunneled Dialysis Catheters
Clinical Journal of the American Society of Nephrology, 11/06/09
Jain G et al. – Heparin coating decreases the frequency of catheter–related bacteremia but does not reduce the frequency of catheter malfunction.
Related Articles
Association of Dialysis Modality and Cardiovascular Mortality in Incident Dialysis Patients
Clinical Journal of the American Society of Nephrology, 10/06/09
Relevance Score: 91%
Hospitalizations in Patients Treated Sequentially by Chronic Hemodialysis and Continuous Peritoneal Dialysis
Advances in Peritoneal Dialysis, 10/21/09
Relevance Score: 90%
Medication Apprehension and Compliance among Dialysis Patients - A Comprehensive Guidance Attitude
Nephron: Clinical Practice, 11/06/09
Relevance Score: 89%
Health-related quality of life in dialysis patients with HCV infection
The International Journal of Artificial Organs, 10/30/09
Relevance Score: 89%
Is Maximum Conservative Management an Equivalent Treatment Option to Dialysis for Elderly Patients with Significant Comorbid Disease
Clinical Journal of the American Society of Nephrology, 10/08/09
Relevance Score: 89%
Today in Dialysis...keeping you current
Receive free subspecialty "5-minute updates" via email
Plasma Ghrelin Levels Are Associated with Coronary Microvascular and Endothelial Dysfunction in Peritoneal Dialysis Patients
Renal Failure, 11/25/09
Hepatocyte Growth Factor/Activin A/Follistatin System Activation during Hemodialysis with Different Low Molecular Weight Heparins
Renal Failure, 11/25/09
Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study
Nephrology Dialysis Transplantation, 11/24/09
Article Search
Sponsor


See Latest Articles


